The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis

Obesity Surgery

Volumn 25, Issue 9, 2015, Pages 1604-1609

  Cheung, Douglas ^a   Switzer, Noah J ^a   Ehmann, David ^a   Rudnisky, Christopher ^a   Shi, Xinzhe ^b   Karmali, Shahzeer ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

Bariatric surgery; Complications; Diabetic retinopathy; Roux en Y gastric bypass; Systematic review; Type 2 diabetes

Indexed keywords

ARTICLE; BARIATRIC SURGERY; CASE STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; HEALTH IMPACT ASSESSMENT; HUMAN; META ANALYSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; COMPLICATION;

BARIATRIC SURGERY; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS;

EID: 84938338598     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1539-9     Document Type: Article

References (30)

1. Pi-Sunyer FX. The medical risks of obesity. Obes Surg. 2002;12 Suppl 1:6S–11.
2. Ghoorah K, et al. Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care. 2014: p. [Epub ahead of print].
3. Petrovic MA et al. Correlation between metabolic controls and changes in retina in patients having diabetes. Med Pregl. 2014;67(1–2):49–54.
4. Gray SP, Jandeleit-Dahm K. The pathobiology of diabetic vascular complications–cardiovascular and kidney disease. J Mol Med (Berl). 2014;92(5):441–52.
5. Gloy VL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
6. Lannoo M, Dillemans B. Laparoscopy for primary and secondary bariatric procedures. Best Pract Res Clin Gastroenterol. 2014;28(1):159–73.
7. Aminian A et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10(4):576–82.
8. Brethauer SA et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 636–7.
9. Heneghan HM et al. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013;9(1):7–14.
10. Johnson BL et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–56. discussion 556–8.
11. Leong WB, Taheri S. The role of bariatric surgery in the treatment of type 2 diabetes mellitus. J R Coll Physicians Edinb. 2012;42(3):194–8.
12. Silva RA, Morton JM, Moshfeghi DM. Severe worsening of diabetic retinopathy following bariatric surgery. Ophthalmic Surg Laser Imag Retina. 2013;44 Online(6): p. E11-4.
13. Mohite AAF, Shah S, Miras PR, et al. The effects of obesity surgery on diabetic retinopathy. Appetite. 2012;58(3):1171.
14. Zhang X, et al. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4(27): p. [Epub ahead of print].
15. Miras AD et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.
16. Thomas RL et al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. J Diabetes Complications. 2014;28(2):191–5.
17. Varadhan L et al. Bariatric surgery and diabetic retinopathy: a pilot analysis. Obes Surg. 2012;22(3):515–6.
18. Leong WBTS. The progression of diabetic retinopathy post bariatric surgery. Diabetes. 2013;2013(62):A159.
19. Ros Ruiz S. Diabetic nephropathy: changes after diabetes surgery? Nutr Hosp. 2013;28 Suppl 2:57–65.
20. Hellgren KJ, Agardh E, Bengtsson B. Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study. Diabetes. 2014;63(9):3104–11.
21. Fante RJ, Gardner TW, Sundstrom JM. Current and future management of diabetic retinopathy: a personalized evidence-based approach. Diab Manag (Lond). 2013;3(6):481–94.
22. Salehi M, D’Alessio DA. Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014;15(3):171–9.
23. Varadhan L et al. GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res Clin Pract. 2011;94(3):e68–71.
24. Varadhan L et al. The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res Clin Pract. 2014;103(3):e37–9.
25. Dahl-Jorgensen K et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed). 1985;290(6471):811–5.
26. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856):1306–9.
27. Lauritzen T et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983;1(8318):200–4.
28. Parving HH et al. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism. 1983;32(9):943–9.
29. Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52(3):818–23.
30. Stefanidis D et al. Revisional bariatric surgery: perioperative morbidity is determined by type of procedure. Surg Endosc. 2013;27(12):4504–10.